Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 2014-01-09 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-01-31 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2017-11-05 | |
| Director/Board Member | 66 | 2017-04-26 | |
David Bejker
BRD | Director/Board Member | 51 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 3/7/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 2/12/25 | Sell | Chief Technology Officer | 3,104,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -1.90% | +3.12% | +81.70% | +110.88% | 73.45B | |
| +0.87% | +15.32% | +56.99% | +95.59% | 62.99B | |
| +1.71% | -1.22% | +2.71% | +501.29% | 28.05B | |
| +5.53% | +10.78% | +65.41% | +27.26% | 25.42B | |
| +21.96% | +21.98% | +1.54% | +2.50% | 23.3B | |
| +2.28% | +5.65% | +42.00% | -12.34% | 19.45B | |
| 0.00% | -2.78% | +247.46% | +423.83% | 18.16B | |
| +4.97% | +4.09% | +26.91% | +543.53% | 16.53B | |
| +2.39% | +7.96% | +44.96% | +157.77% | 13.16B | |
| Average | +3.78% | +5.80% | +63.30% | +205.59% | 31.17B | |
| Weighted average by Cap. | +2.75% | +6.43% | +63.15% | +169.32% |
Employees
6
